Clinical trial
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
NCT03188185
Study timeline
Study start (actual)2017-06-12Date precision: day
Registry last updated2021-04-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
ALKS 5461DRUG
Sponsors & collaborators
Alkermes, Inc.lead sponsor
Mapped research locations
San JuanPuerto Rico2DallasTexas, United States1AtlantaGeorgia, United States1CincinnatiOhio, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1Oklahoma CityOklahoma, United States1TucsonArizona, United States1MemphisTennessee, United States1Little RockArkansas, United States1DecaturGeorgia, United States1HollywoodFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03188185 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.